Central Blood Pressure in Adolescents and Young Adults

NCT ID: NCT02222077

Last Updated: 2017-09-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-07-31

Study Completion Date

2018-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate in adolescents and young adults:

* the 24h diurnal variation of ambulatory central blood pressure
* the association of central compared to peripheral blood pressure with indices of asymptomatic target-organ damage

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adolescents and young adults (age range 12-25 years)

Exclusion Criteria

* Subjects with any acute or significant chronic disease, with evidence of secondary hypertension, or on regular drug treatment will be excluded
Minimum Eligible Age

12 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Athens

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

George S. Stergiou

Professor of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hypertension Center, 3rd University Department of Medicine, Sotiria Hospital

Athens, Attica, Greece

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Greece

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

George S Stergiou, Professor of Medicine

Role: CONTACT

+302107763117

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

George S Stergiou, Professor of Medicine

Role: primary

+302107763117

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Central BP-TOD

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Office, Home, and Ambulatory Blood Pressure
NCT05297708 ACTIVE_NOT_RECRUITING
Hypertension Chronobiome
NCT03598894 ACTIVE_NOT_RECRUITING
Hybrid Blood Pressure Monitor Validation
NCT01120990 COMPLETED PHASE4